Multiply recurrent pituitary apoplexy treated nonsurgically: illustrative case Authors: Alexander P. Landry, Maíra Cristina Velho, Luma Ghalib, Daniel M. Prevedello Published: 2026 ABSTRACT BACKGROUNDPituitary apoplexy is rare clinical entity resulting from hemorrhage or infarction of a pituitary tumor, typically presenting with headaches, endocrinopathy, and variable neurological manifestations. Recurrent apoplexy, particularly multiply recurrent cases, is exceedingly rare and associated with clinical equipoise in many cases.OBSERVATIONSThe authors report the case of an 85-year-old female who presented with three distinct episodes of pituitary apoplexy over 6 years, each presenting with acute headache in the absence of neurological deficits. Given the patient’s age, lack of neurological symptoms, and personal preference, she did not undergo surgical intervention and was treated with only hormone replacement for hypopituitarism after the second episode.LESSONSThis case highlights that nonsurgical management may be successful in carefully selected cases of pituitary apoplexy, although the risk of recurrence is an important consideration that is often overlooked in cases presenting with mild symptoms. The authors suggest that upfront surgery may be considered in younger patients, even in the setting of mild presentations that do not require emergency intervention, to avoid the potential morbidity of recurrent apoplexy. Better predictors of apoplexy recurrence will be helpful to develop increasingly personalized management strategies for these patients. https://thejns.org/doi/10.3171/CASE26461 Pituitary apoplexy represents a rare clinical phenomenon related to hemorrhage or infarction within a pituitary tumor.1,2 It is typically characterized by an abrupt headache with accompanying endocrinological disturbances and variable neurological manifestations, which can include vision loss, cranial nerve palsies,3,4 and, rarely, phenomena including cerebral salt wasting,5 stroke,6,7 or subarachnoid hemorrhage.8 Management depends almost entirely on the clinical presentation and usually involves endocrine replacement with either emergency resection or close observation in cases with less severe presentations or when surgery is contraindicated.2,9–13 While some papers have noted similar rates of visual improvement between conservative and surgically managed patients,14–16 these findings may reflect selection bias in actual practice,17,18and other groups have found better visual outcomes after surgical intervention.19 Additionally, consensus on the optimal timing of surgical intervention, when needed, is limited.20,21 Risk factors for the development of apoplexy in the setting of a pituitary adenoma include pregnancy, the use of anticoagulant/antithrombotic medications, macroadenomas, major surgery, and nonfunctional tumors,22–24 although these factors are rarely incorporated into routine clinical decision-making. Cases of recurrent pituitary apoplexy are particularly rare, and optimizing their management will rely on a growing body of case reports in the literature. Here we present an extremely rare case of multiply recurrent pituitary apoplexy treated successfully with nonsurgical management on three occasions. Illustrative Case We report the case of an 85-year-old female who initially presented to the emergency department in 2019 for an acute-onset headache. Her medical history is significant for coronary artery disease, for which she takes aspirin 81 mg daily; hypertension; and stage 3 chronic kidney disease. She was neurologically intact and neuroimaging (CT and MRI) was consistent with a pituitary region hemorrhage, which was abutting but not distorting the optic chiasm (Fig. 1). She was monitored closely and did not develop any neurological or endocrinological deficits; she preferred to avoid any upfront surgery and was therefore discharged without intervention. She remained clinically well in the interim and did not return for follow-up imaging. FIG. 1.Initial presentation with apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, demonstrating hyperintense hemorrhage within the sella (red arrow). B: Sagittal CT scan similarly demonstrating hyperdensity consistent with acute hemorrhage. C: Coronal T1-weighted MR image without contrast, redemonstrating the hemorrhagic sella, which abuts but does not distort the optic chiasm (green arrow). D: Coronal T2-weighted MR image without contrast, demonstrating corresponding hypointensity, with a cleft of CSF present below the optic chiasm. Initial presentation with apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, demonstrating hyperintense hemorrhage within the sella (red arrow). B: Sagittal CT scan similarly demonstrating hyperdensity consistent with acute hemorrhage. C: Coronal T1-weighted MR image without contrast, redemonstrating the hemorrhagic sella, which abuts but does not distort the optic chiasm (green arrow). D: Coronal T2-weighted MR image without contrast, demonstrating corresponding hypointensity, with a cleft of CSF present below the optic chiasm. Four years later, in January 2023, she was awoken from sleep with another acute-onset severe headache; imaging again revealed evidence of pituitary apoplexy without associated compression of the optic chiasm (Fig. 2). She had no evidence of visual compromise or other cranial neuropathies, and therefore surgical intervention was again deferred after a thorough discussion with the patient about its risks and potential benefits. From an endocrinological standpoint, she initially passed the adrenocorticotropic hormone stimulation test, with serum cortisol increasing from 4.5 to 41.38 μg/dL; however, 5 days later her 6 am cortisol level was 1.09 and sydrocortisone replacement therapy was subsequently initiated. Her initial thyroid-stimulating hormone level was 2.4 with a free thyroxine level of 1.0, but these dropped to 0.18 and 0.74, respectively; she was therefore started on levothyroxine replacement. Her insulin-like growth factor 1 and prolactin levels were low to normal at 212 and 5.4, respectively. She remained neurologically intact throughout her hospitalization and was ultimately discharged to a rehabilitation facility. Imaging in 2024 demonstrated complete resolution of her apoplexy (Fig. 3). FIG. 2.Second presentation of apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, demonstrating hyperintense hemorrhage within the sella (red arrow) and the overlying optic chiasm (green arrow), which does not appear to be distorted. B: Sagittal CT scan similarly demonstrating hyperdensity of the sellar lesion. C:Coronal T1-weighted MR image without contrast, redemonstrating the hemorrhagic sella abutting the optic chiasm. D: Coronal T2-weighted MR image without contrast, demonstrating corresponding hypointensity of the lesion and its relationship with the optic chiasm. FIG. 3.Radiological resolution of apoplexy after the first recurrent episode. A: Coronal T2-weighted MR image demonstrating involution of the hemorrhage with a normal-appearing pituitary region (blue arrow). There is now significant space between the pituitary gland and the optic chiasm (green arrow), with the intervening infundibulum clearly visible. B: The same anatomy is demonstrated on a coronal T1-weighted MR image without contrast, with no evidence of hyperintensity in the pituitary region. Second presentation of apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, demonstrating hyperintense hemorrhage within the sella (red arrow) and the overlying optic chiasm (green arrow), which does not appear to be distorted. B: Sagittal CT scan similarly demonstrating hyperdensity of the sellar lesion. C:Coronal T1-weighted MR image without contrast, redemonstrating the hemorrhagic sella abutting the optic chiasm. D: Coronal T2-weighted MR image without contrast, demonstrating corresponding hypointensity of the lesion and its relationship with the optic chiasm. Radiological resolution of apoplexy after the first recurrent episode. A: Coronal T2-weighted MR image demonstrating involution of the hemorrhage with a normal-appearing pituitary region (blue arrow). There is now significant space between the pituitary gland and the optic chiasm (green arrow), with the intervening infundibulum clearly visible. B: The same anatomy is demonstrated on a coronal T1-weighted MR image without contrast, with no evidence of hyperintensity in the pituitary region. Almost 3 years later, in December 2025, she again presented with sudden intractable headaches without any visual decline or other neurological deficits. Neuroimaging was again consistent with apoplexy and was comparable to her previous presentations (Fig. 4). She remained neurologically intact and again elected to avoid any surgical intervention; she was therefore discharged without surgical intervention. On the most recent follow-up, she remained independent and neurologically intact. She received stable doses of hormone replacement (15 mg am and 10 mg pm of hydrocortisone and 75 μg daily of levothyroxine) with plans to reduce her steroid dose over time. Cessation of aspirin has been recommended by her neurosurgical team, although the risk/benefit ratio must be weighed against her coronary artery disease. FIG. 4.Third presentation of apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, again demonstrating hyperintense hemorrhage (red arrow). B: Sagittal CT scan similarly demonstrating hyperdensity of the acute hemorrhage. C: Coronal T1-weighted MR image with gadolinium contrast enhancement, demonstrating the relationship between the hemorrhagic lesion and the optic chiasm (green arrow). D: Axial T2-weighted MR image without contrast, demonstrating the hypointensity of the lesion. Third presentation of apoplexy. A: Sagittal T1-weighted MR image without contrast enhancement, again demonstrating hyperintense hemorrhage (red arrow). B: Sagittal CT scan similarly demonstrating hyperdensity of the acute hemorrhage. C: Coronal T1-weighted MR image with gadolinium contrast enhancement, demonstrating the relationship between the hemorrhagic lesion and the optic chiasm (green arrow). D: Axial T2-weighted MR image without contrast, demonstrating the hypointensity of the lesion. Informed Consent Informed consent was not necessary because the patient did not undergo surgery. Discussion Observations In this report, we present the first case, to our knowledge, of a multiply recurrent pituitary apoplexy treated entirely without surgical management, due largely to the patient’s advanced age, mild clinical presentations, and preference to avoid surgery. While recurrent pituitary apoplexy is a rare entity, it must be considered carefully when choosing management strategies for patients having undergone an initial episode. Multiple hemorrhages, even with intervening radiological resolution, can be associated with considerable morbidity, and upfront resection may therefore be a consideration as a preventative strategy, even in the absence of visual compromise. While this is particularly important in younger patients who have the highest lifetime risk of recurrence, older patients are also susceptible to multiple recurrences over a short time frame, as illustrated in this case. Furthermore, despite the good outcome in the presented case, upfront resection may have prevented the subsequent endocrinopathy and avoided any need to cease antithrombotic therapy, emphasizing the importance of thoroughly discussing the risks and benefits of upfront surgery with all patients presenting with pituitary apoplexy. Predicting which patients will have recurrence of apoplexy is also challenging, particularly among those who do not receive upfront surgical intervention. One study found that prior radiation therapy and prior subtotal resection were both associated with recurrent cases of apoplexy, with a mean time to recurrence of approximately 50 months among 11 patients.25 A retrospective series found that 3% of apoplexy cases recurred, with recurrent cases being associated with larger tumors, cavernous sinus invasion, and prior cabergoline therapy compared to cases without recurrence; the median time to recurrence was 18 months in this series.26 Moreover, multiply recurrent apoplexy after surgical intervention is extremely rare and has been shown to be related to the presence of multiple co-occurring tumors.27,28 Notably, these risk factors largely relate to the resectability of disease rather than intrinsic tumor properties or patient factors that may predispose to recurrent apoplexy after nonsurgical management. While there is increasing recognition of the role of molecular characterization of these lesions,29,30 more work is needed to understand how this correlates with apoplexy risk over time. Lessons The successful management of a twice recurrent case of pituitary apoplexy in an older patient with minimal deficits highlights the need to better understand the natural history of pituitary neuroendocrine tumors in order to better predict outcomes and individualize patient care. Ongoing work to understand the molecular substrates of these heterogeneous tumors may provide new insights into the mechanisms of apoplexy and help tailor therapy and/or anticipatory surveillance accordingly. We demonstrate the importance of thorough patient ­counseling in cases of apoplexy in which urgent intervention is not required, given the real possibility of recurrent episodes and their associated morbidity. Until better outcome predictors are developed, we highlight that the risk of multiple recurrent episodes of apoplexy with its associated morbidity may itself be a relative indication for upfront surgical intervention, particularly among younger patients who have the highest absolute lifetime risk of recurrence, even when the clinical presentation does not demand immediate intervention. Overall, this work adds to the growing literature on the rare phenomenon of ­recurrent pituitary apoplexy and highlights the nuances of its management. Disclosures D. Prevedello reported consulting for Stryker, Integra, Leica, and BK Medical; and royalties from KLS-Martin, Mizuho, and ACE Medical. Author Contributions Conception and design: Prevedello, Landry, Ghalib. Acquisition of data: Landry, Ghalib. Analysis and interpretation of data: Landry, Velho, Ghalib. Drafting the article: Landry, Velho. Critically revising the article: Prevedello, Landry, Velho. Reviewed submitted version of manuscript: Prevedello, Landry, Ghalib. Approved the final version of the manuscript on behalf of all authors: Prevedello. Administrative/technical/material support: Prevedello. Correspondence Daniel M. Prevedello: The Ohio State University Wexner Medical Center, Columbus, OH. daniel.prevedello@osumc.edu.